Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?. Issue 5 (20th January 2020)

• Record Type: Journal Article
• Authors: Tarantini, Giuseppe; Nai Fovino, Luca
• Is Part Of: Catheterization and cardiovascular interventions. Volume 95:Issue 5(2020)
• Page Start: E163
• Page End: E164
• Publication Date: 2020-01-20
• Subjects: Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.28690
• Languages: English
• ISSNs: 1522-1946

Abstract

Key Points: Chronic liver disease is associated with increased operative risk of open‐heart surgery. In this study, transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) carried high periprocedural mortality, but transfemoral TAVR appeared to be superior to SAVR in terms of long‐term survival. Better risk stratification tools are needed for patients with liver dysfunction to avoid futile TAVR and SAVR procedures.